Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-28T15:22:46.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Abnormalities of cholesterol metabolism in diabetes

Published online by Cambridge University Press:  28 February 2007

Gerald H. Tomkin  and
Daphne Owens
Gerald H. Tomkin
Affiliation:
Department of Diabetes and Endocrinology, The Adelaide Hospital, Dublin 8, Republic of Ireland
Daphne Owens
Affiliation:
Department of Biochemisry, Royal College of Surgeons in Ireland, dublin 2, Republic of Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Meeting Report
Information
Proceedings of the Nutrition Society , Volume 50 , Issue 3 , December 1991 , pp. 583 - 589
Copyright
Copyright © The Nutrition Society 1991

References

Armstrong, V. W., Cremer, P., Eberle, E., Manke, A., Schulz, F., Wieland, H., Kreuzer, H. & Seidel, D. (1986). The association between serum Lp(a) concentration and angiographically assessed coronary atherosclerosis. Atherosclerosis 62, 249–257.CrossRefGoogle ScholarPubMed
Bagdade, J. D., Ritter, M. L. & Subbaiah, P. V. (1991). Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. European Journal of Clinical Investigation 21, 161–167.CrossRefGoogle ScholarPubMed
Brand, F. N., Abbott, R. D. & Kannel, W. B. (1989). Diabetes, intermittent claudication and risk of cardiovascular events. The Framingham Study. Diabetes 38, 504–509.CrossRefGoogle ScholarPubMed
Brown, M. S., Dana, S. E. & Goldstein, J. L. (1974). The regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolaemia. Journal of Biological Chemistry 249, 789–796.CrossRefGoogle Scholar
Brownlee, M., Vlassara, H. & Cerami, A. (1985). Non-enzymatic glycosylation products on collagen covalently trap low density lipoprotein. Diabetes 34, 938–941.CrossRefGoogle Scholar
Castelli, W. P., Garrison, R. T., Wilson, P. W. K., Abbott, R. D., Kalousdian, S. & Kannel, W. B. (1986). Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. Journal of the American Medical Association 256, 2835–2838.CrossRefGoogle ScholarPubMed
Dean, J. D., Jones, C. J. H., Hutchinson, S. J., Peters, R. J. & Henderson, A. H. (1991). Hyperinsulinaemia and microvascular angina (“syndrome X”). Lancet 337, 456–457.Google ScholarPubMed
DeFronzo, R. A. & Ferrannini, E. (1991). Insulin resistance. A multifaced syndrome responsible for NIDDM. Obesity, Hypertension, Dyslipidemia and atherosclerotic vascular disease. Diabetes Care 14, 173–194.CrossRefGoogle Scholar
Devery, R. A. M., O'Meara, N., Collins, P. B., Johnson, A., Scott, L. & Tomkin, G. H. (1987). A comparative study of the rate-limiting enzymes of cholesterol synthesis, esterification and catabolism with alloxan-induced diabetic rat and rabbit. Comparative Biochemistry and Physiology 88B, 547–550.Google Scholar
Fontbonne, A., Eschwege, E., Cambien, F., Richard, J. L., Ducimetiere, P., Thibult, N., Warnet, J. M., Claude, J. -R. & Rosselin, G. E. (1989). Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32, 300–304.CrossRefGoogle ScholarPubMed
Fuller, J. H., Shipley, M. J., Rose, G., Jarrett, R. J. & Keen, H. (1983). Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study. British Medical Journal 287, 867–870.CrossRefGoogle ScholarPubMed
Gibbons, G. F. (1990). Assembly and secretion of hepatic very-low-density lipoprotein. Biochemical Journal 268, 1–13.CrossRefGoogle ScholarPubMed
Glomset, J. A. (1968). The plasma lecithin:cholesterol acyltransferase reaction. Journal of Lipid Research 9, 155–167.CrossRefGoogle Scholar
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B. & Dauber, T. R. (1977). Diabetes, blood lipids and the role of obesity in coronary heart disease risk for men. The Framingham Study. Annals of Internal Medicine 87, 393–397.CrossRefGoogle ScholarPubMed
Haffner, S. M., Tuttle, K. R. & Rainwater, D. L. (1991). Decrease of lipoprotein(a) with improved glycaemic control in IDDM subjects. Diabetes Care 14, 302–307.CrossRefGoogle ScholarPubMed
James, R. W. & Pometta, D. (1990). Differences in lipoprotein subfraction composition and distribution between Type 1 diabetic men and control subjects. Diabetes 39, 1158–1164.CrossRefGoogle ScholarPubMed
Kostner, G. M., Avogaro, P., Cazzaloto, G., Marth, E., Bittolo-Bon, G. & Quinci, G. B. (1981). Lipoprotein Lp(a) and the risk of myocardial infarction. Atherosclerosis 38, 51–61.CrossRefGoogle Scholar
Krolewski, A. S., Kosinski, E. J., Warram, J. H., Leland, O. S., Busick, E. J. & Asmal, A. C. (1987 a). Magnitude and determinants of coronary artery disease in juvenile onset, insulin-dependent diabetes mellitus. American Journal of Cardiolog 59, 750–755.CrossRefGoogle ScholarPubMed
Krolewski, A. S., Warram, J. H., Rand, L. I. & Kahn, C. R. (1987 b). Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. New England Journal of Medicin 317, 1390–1398.Google Scholar
Levitsky, L. L., Scanu, A. M. & Gould, S. H. (1991). Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care 14, 283–287.CrossRefGoogle ScholarPubMed
Lyons, T. J., Klein, R. L., Baynes, J. W., Stevenson, H. C. & Lopes-Virella, M. F. (1987). Stimulation of cholesterol ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins. Diabetologia 30, 916–923.CrossRefGoogle Scholar
McBrinn, S., Collins, P., Johnson, A., Owens, D. & Tomkin, G. (1991). Normocholesterolaemic diabetic subjects have elevated leucocyte cholesterol content. Diabetologia (In the Press).Google Scholar
Mazzone, T., Foster, D. & Chait, A. (1984). In vitro stimulation of low density lipoprotein degradation by insulin. Diabetes 33, 333–338.CrossRefGoogle Scholar
Nikkila, E. A. & Hormila, P. (1978). Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes 27, 1078–1086.CrossRefGoogle ScholarPubMed
O'Meara, N. M. G., Devery, A. M., Owens, D., Collins, P., Johnson, A. H. & Tomkin, G. H. (1990). Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes 39, 62–33.CrossRefGoogle ScholarPubMed
Owens, D., Maher, V., Collins, P., Johnson, A. & Tomkin, G. H. (1990 a). Cellular cholesterol regulation – a defect in the Type 2 (non-insulin-dependent) diabetic patient in poor metabolic control. Diabetologi 33, 93–99.CrossRefGoogle ScholarPubMed
Owens, D., Stinson, J., Collins, P., Johnson, A. & Tomkin, G. H. (1990 b). Improvement in the regulation of cholesterologenesis in diabetes: the effect of reduction in serum cholestrol by simvastatin. Diabetic Medicin 8, 151–156.CrossRefGoogle Scholar
Reaven, G. (1988). The role of insulin resistance in human disease. Diabetes 37, 1595–1607.CrossRefGoogle ScholarPubMed
Reckless, P. D., Betteridge, D. J., Wu, P., Payne, B. & Galton, D. J. (1978). High density and low density lipoproteins and prevalence of vascular disease in diabetes mellitus. British Medical Journal i, 883–886.CrossRefGoogle Scholar
Reichl, D. & Miller, N. (1989). Pathology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Atherosclerosis 9, 785–797.Google Scholar
Sosenko, J. M., Breslow, J. L., Miettenen, O. S. & Gabbay, K. H. (1980). Hyperglycaemia and plasma lipid levels. A prospective study of young insulin-dependent diabetic patients. New England Journal of Medicine 302, 650–654.CrossRefGoogle Scholar
Steinbrecher, U. P. & Witztum, J. L. (1984). Glycosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 7, 135–143.Google Scholar
Stout, R. W. (1970). Development of vascular lesions in insulin-treated animals fed a normal diet. British Medical Journal 3, 685–687.CrossRefGoogle ScholarPubMed
Stout, R. W. (1990). Insulin and atheroma. 20-Yr perspective. Diabetes Care 13, 631–654.CrossRefGoogle ScholarPubMed
Stout, R. W. & Vallance-Owen, J. (1969). Insulin and atheroma. Lancet i, 1078–1080.CrossRefGoogle Scholar
Stinson, J., Owens, D., Collins, P., Johnson, A. & Tomkin, G. H. (1991). The effects of hyperinsulinaemia and/or hyperglycaemia on cholesterol synthesis in insulin-dependent diabetic patients. Diabetic Medicine (In the Press).Google Scholar
Streja, D. A., Marliss, E. B. & Stciner, G. (1977). The effects of prolonged fasting on plasma triglyceride kinetics in man. Metabolism 26, 505–516.CrossRefGoogle ScholarPubMed
Taskinen, M. R. (1987). Lipoprotein lipase in diabetes. Diabetes Metabolism Reviews 3, 551–570.CrossRefGoogle ScholarPubMed
West, K. M. (1978). Epidemiology of Diabetes and its Vascular Lesions, pp. 159–189. New York: Elsevier.Google Scholar
Winocour, P. H., Durrington, P. N., Ishola, M., Anderson, D. C. & Cohen, H. (1987). Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. British Medical Journal 294, 1648–1654.CrossRefGoogle ScholarPubMed
Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M. & Reaven, G. (1989). Risk factors for coronary artery disease in healthy persons with hyperinsulinaemia and normal glucose tolerance. New England Journal of Medicine 320, 702–706.CrossRefGoogle ScholarPubMed